Srpt nasdaq.
The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...
View real-time SRPT stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: …CAMBRIDGE, Mass., May 12, 2023--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration ...Current. -$0.28. 1 Month Ago. -$0.64. 3 Months Ago. -$0.52. Sarepta Therapeutics Inc. analyst estimates, including SRPT earnings per share estimates and analyst recommendations.SRPT SRPT AFTER HOURS QUOTE SRPT LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on November 30, …Turning to the calls side of the option chain, the call contract at the $155.00 strike price has a current bid of $20.40. If an investor was to purchase shares of SRPT stock at the current price ...
Turning to the calls side of the option chain, the call contract at the $135.00 strike price has a current bid of $32.50. If an investor was to purchase shares of SRPT stock at the current price ...Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sarepta Therapeutics Inc (Symbol: SRPT), where a total volume of 3,812 ...
Nov 29, 2023 · Transcript : Sarepta Therapeutics, Inc. Presents at UBS Biopharma Conference 2023, Nov-09-2023 09:00 AM. Nov. 09. CI. Sarepta Therapeutics Insider Bought Shares Worth $2,001,800, According to a Recent SEC Filing. Nov. 06. MT. Sarepta Therapeutics Insider Bought Shares Worth $3,940,500, According to a Recent SEC Filing. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.12 Nis 2023 ... Hartaj Singh, Managing Director at Opco, recommends Astria Therapeutics (NASDAQ:ATXS), Biomea (NASDAQ:BMEA) and Sarepta (NASDAQ:SRPT)View real-time SRPT stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: …
(NASDAQ: SRPT) Sarepta Therapeutics stock price per share is $84.44 today (as of Dec 1, 2023).
Funds + ETFs. After-Hours Quotes. News + Insights. P/E & PEG Ratios. Nasdaq provides market information opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Nasdaq MarketSIte.
Sarepta Therapeutics (NASDAQ:SRPT) Q3 results:Revenues: $143.9M (+45.4%); product sales: $121.4M (+22.6%); collaboration revenue: $22.5M (primarily from...Sarepta Therapeutics, Inc. (SRPT) NasdaqGS - NasdaqGS Real-time price.Find the latest historical data for Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) at Nasdaq.com.Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.With the business potentially at an important milestone, we thought we'd take a closer look at Sarepta Therapeutics, Inc.'s (NASDAQ:SRPT) future prospects. Sarepta Therapeutics, Inc., a commercial ...According to the issued ratings of 18 analysts in the last year, the consensus rating for Sarepta Therapeutics stock is Moderate Buy based on the current 3 hold ratings and 15 buy ratings for SRPT. The average twelve-month price prediction for Sarepta Therapeutics is $153.10 with a high price target of $224.00 and a low price target of $40.00 ...Insiders have sold a total of 15,858 Sarepta Therapeutics shares in the last 24 months for a total of $1,695,111.36 sold. Which members of congress are trading Sarepta Therapeutics? Josh Gottheimer (D-NJ) and Daniel S. Goldman (D-NY) have bought shares of Sarepta Therapeutics in the last year totaling $48,500.
Sarepta Therapeutics (NASDAQ:SRPT) fell victim to the FDA's whims as the stock tumbled more than 3 percent following the issues raised by the FDA against its drug candidate Vyondys 53 (golodirsen ...Barry was up about 5.5% on the purchase at the high point of today's trading session, with SRPT trading as high as $83.11 at last check today. VIDEO: Monday 11/6 Insider Buying Report: RELY, SRPTSarepta Therapeutics (NASDAQ:SRPT) shares plunged more than 37% yesterday. The fall comes after the company’s Elevidys gene therapy failed to meet the key goal in a late-stage trial. The ...IvelinRadkov. Genetic medicines maker Sarepta Therapeutics (NASDAQ:SRPT) on Thursday said it had submitted a biologics license application (BLA) to the U.S. FDA for an accelerated approval for ...Shares of the rare disease juggernaut Sarepta Therapeutics ( SRPT -1.07%) fell by 12.6% through the first three and a half days of trading this week, according to data provided by S&P Global ...Nov 29, 2023 · Transcript : Sarepta Therapeutics, Inc. Presents at UBS Biopharma Conference 2023, Nov-09-2023 09:00 AM. Nov. 09. CI. Sarepta Therapeutics Insider Bought Shares Worth $2,001,800, According to a Recent SEC Filing. Nov. 06. MT. Sarepta Therapeutics Insider Bought Shares Worth $3,940,500, According to a Recent SEC Filing.
Sarepta Therapeutics, Inc. 81.28 +0.88 (1.09%) At close: Nov 30, 2023, 4:00 PM 81.30 +0.02 (0.02%) After-hours: Nov 30, 2023, 7:58 PM EST Overview Financials …
SRPT Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. 104.49. -1.38 ( -1.30%)Feb 28, 2023 · CAMBRIDGE, Mass., February 28, 2023--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter ... Dec 2, 2023 · Current Trading Halts. Nov 30, 2023. Halt times displayed are Eastern Time (ET). updating.... Pause Threshold Price. If a security is subject to a Trading Pause, the Pause Threshold Price field will contain the reference threshold price that deviates 10% from a print on the Consolidated Tape that is last sale eligible as compared to every print ... (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the UBS ...Sarepta Therapeutics Stock Down 0.3 %. Shares of NASDAQ:SRPT opened at $82.58 on Tuesday. The company has a market cap of $7.73 billion, a price-to-earnings ratio of -10.55 and a beta of 0.96.May 11, 2023 · Fintel reports that on May 15, 2023, UBS maintained coverage of Sarepta Therapeutics (NASDAQ:SRPT) with a Buy recommendation.. Analyst Price Forecast Suggests ∞% Upside. As of May 11, 2023, the ... We would like to show you a description here but the site won’t allow us.$51.56 -0.50 -0.96% Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.A high-level overview of Sarepta Therapeutics, Inc. (SRPT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
(NASDAQ: SRPT) Sarepta Therapeutics stock price per share is $84.44 today (as of Dec 1, 2023).
Sarepta Therapeutics, Inc. (SRPT) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 82.58 -0.29 (-0.35%) At close: 04:00PM EST 82.79 +0.21 (+0.25%) After hours: 04:59PM EST 1d...
SAREPTA THERAPEUTICS INC ( SRPT) is a large-cap stock in the Biotechnology & Drugs industry. The rating using this strategy is 83% based on the firm’s underlying fundamentals and the stock’s ...Fintel reports that on May 15, 2023, Credit Suisse maintained coverage of Sarepta Therapeutics (NASDAQ:SRPT) with a Neutral recommendation.. Analyst Price Forecast Suggests ∞% Upside. As of May ...CAMBRIDGE, Mass., May 12, 2023--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration ...Richard Barry, who is a director at Sarepta Therapeutics, Inc. (NASDAQ:SRPT), bought 50,000 shares of the company at $78.81 per share. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s CEO Douglas Ingram also bought 25,225 shares of the company earlier this month at $79.36 per share.May 23, 2023 · Hailshadow. Sarepta Therapeutics (NASDAQ:SRPT) is a large (~$14 billion market cap) biopharmaceutical company that markets 3 RNA-targeted products for Duchenne muscular dystrophy (DMD) patients.In ... Douglas S Ingram, President & CEO at Sarepta Therapeutics SRPT, reported a large insider buy on November 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities ...Sarepta Therapeutics, Inc. (SRPT) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 82.58 -0.29 (-0.35%) At close: 04:00PM EST 82.79 +0.21 (+0.25%) After hours: 04:59PM EST 1d... Fintel reports that on May 15, 2023, Credit Suisse maintained coverage of Sarepta Therapeutics (NASDAQ:SRPT) with a Neutral recommendation.. Analyst Price Forecast Suggests ∞% Upside. As of May ...CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 25, 2023-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2023 financial results after the Nasdaq Global Market closes on Tuesday, May 2, 2023.Subsequently, at 4:30 p.m. E.T., the Company will host …Oct 20, 2023 · Sarepta Therapeutics Inc (Symbol: SRPT) saw options trading volume of 7,627 contracts, representing approximately 762,700 underlying shares or approximately 79.9% of SRPT's average daily trading ... Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) · SRPT Latest After Hours Trades.
US8036071004. Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. Show more.Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shareholders (or potential shareholders) will be happy to see that the Independent Director, Richard Barry, recently bought a whopping US$3.9m worth of stock, at a price of US$78.81.While that only increased their holding size by 1.7%, it is still a big swing by our standards. View our …Chambers was up about 4.0% on the purchase at the high point of today's trading session, with SRPT trading as high as $108.56 at last check today. VIDEO: Thursday 9/15 Insider Buying Report: VVX, SRPTInstagram:https://instagram. best banks for fha mortgagesstockscannerzynerba pharmaceuticalsplug stoc CAMBRIDGE, Mass., February 28, 2023 -- ( BUSINESS WIRE )--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare … nickel worth 1964high dividend reits Sarepta Therapeutics, Inc. (SRPT) Stock Price | Stock Quote Nasdaq - MarketScreener SAREPTA THERAPEUTICS, INC. Sarepta Therapeutics, Inc. Stock … best small caps stocks Sarepta Therapeutics (NASDAQ:SRPT) Q3 results:Revenues: $143.9M (+45.4%); product sales: $121.4M (+22.6%); collaboration revenue: $22.5M (primarily from...Sarepta Therapeutics Inc stock price (SRPT) NASDAQ: SRPT. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Sarepta Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.